Predictive Factors for the Success of Vaginal Dinoprostone for the Induction of Labour

References

• Levine LD. Cervical ripening: why we do what we do. Semin Perinatol. 2020;44(2):151216. doi:10.1016/j.semperi.2019.151216
   PubMed Web of Science ®Google Scholar
• Socha MW, Flis W, Wartęga M, et al. A review of the mechanism of action and clinical applications of osmotic dilators for cervical ripening in the induction of labor and in gynecology procedures. Med Sci Monit. 2023;27(29):e940127.
   Google Scholar
• Sah MK, Padhye SM. Mifepristone versus intracervical prostaglandin E2 gel for cervical ripening in primigravid patients at term. Int J Reprod Contracep Obstet Gynecol. 2018;7(3):824–828. doi:10.18203/2320-1770.ijrcog20180520
   Google Scholar
• Tenore JL. Methods for cervical ripening and induction of labor. Am Family Phys. 2003;67(10):2123–2128.
   PubMed Web of Science ®Google Scholar
• Bakker R, Pierce S, Myers D. The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach. Arch Gynecol Obstetrics. 2017;296(2):167–179. doi:10.1007/s00404-017-4418-5
   PubMed Web of Science ®Google Scholar
• Jiménez NL, Sánchez FG, Pailos RH, et al. Prediction of an effective cervical ripenning in the induction of labour using vaginal dinoprostone. Sci Rep. 2023;13(1):6855. doi:10.1038/s41598-023-33974-7
   PubMed Web of Science ®Google Scholar
• Daykan Y, Biron-Shental T, Navve D, et al. Prediction of the efficacy of dinoprostone slow release vaginal insert (Propess) for cervical ripening: a prospective cohort study. J Obstet Gynaecol Res. 2018;44(9):1739–1746. doi:10.1111/jog.13715
   PubMed Web of Science ®Google Scholar
• Stafford RS. Regulating off-label drug use—rethinking the role of the FDA. New Engl J Med. 2008;358(14):1427–1429. doi:10.1056/NEJMp0802107
   PubMed Web of Science ®Google Scholar
• Wang H, Hong S, Liu Y, et al. Controlled-release dinoprostone insert versus Foley catheter for labor induction: a meta-analysis. J Matern Fetal Neonatal Med. 2016;29(14):2382–2388. doi:10.3109/14767058.2015.1086331
   PubMed Web of Science ®Google Scholar
• Melamed N, Ben-Haroush A, Kremer S, et al. Failure of cervical ripening with prostaglandin-E2 can it be predicted? J Matern Fetal Neonatal Med. 2010;23(6):536–540. doi:10.3109/14767050903197076
   PubMed Web of Science ®Google Scholar
• Witter FR. Prostaglandin E2 preparations for preinduction cervical ripening. Clin Obstet Gynecol. 2000;43(3):469–474. doi:10.1097/00003081-200009000-00007
   PubMed Web of Science ®Google Scholar
• Hiersch L, Borovich A, Gabbay-Benziv R, et al. Can we predict successful cervical ripening with prostaglandin E2 vaginal inserts? Arch Gynecol Obstetr. 2017;295(2):343–349. doi:10.1007/s00404-016-4260-1
   PubMed Web of Science ®Google Scholar
• Ting N, Ding D, Wei Y. Comparison of the dinoprostone vaginal insert and dinoprostone tablet for the induction of labor in primipara: a retrospective cohort study. J Clin Med. 2022;11(12):3519. doi:10.3390/jcm11123519
   PubMed Web of Science ®Google Scholar
• Ryu A, Kim TH. Re: a randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E2 (OPRA study): comments on outpatient cervical ripening. BJOG. 2016;123(12):2049–2050. doi:10.1111/1471-0528.14047
   PubMed Web of Science ®Google Scholar
• Taliento C, Manservigi M, Tormen M, et al. Safety of misoprostol vs dinoprostone for induction of labor: a systematic review and meta-analysis. Eur J Obstetrics Gynecol Reprod Biol. 2023;289:108–128. doi:10.1016/j.ejogrb.2023.08.382
   PubMed Web of Science ®Google Scholar
• Murano M, Chou D, Costa ML, et al. Using the WHO-INTEGRATE evidence-to-decision framework to develop recommendations for induction of labour. Health Res Policy Syst. 2022;20(1):125. doi:10.1186/s12961-022-00901-7
   PubMed Web of Science ®Google Scholar
• Kolkman DG, Verhoeven CJ, Brinkhorst SJ, et al. The Bishop score as a predictor of labor induc- tion success: a systematic review. Am J Perinatol. 2013;30(8):625–630. doi:10.1055/s-0032-1331024
   PubMed Web of Science ®Google Scholar
• Obut M, Yıldız GA, Bademkıran MH, et al. Predictor factors in the success of slow-release dinoprostone used for cervical ripening in pregnancies with premature rupture of membranes. Eurasian J Med. 2022;54(1):72–76. doi:10.5152/eurasianjmed.2022.21237
   PubMed Web of Science ®Google Scholar
• Zhang J, Bricker L, Wray S, Quenby S. Poor uter- ine contractility in obese women. BJOG. 2007;114(3):343–348. doi:10.1111/j.1471-0528.2006.01233.x
   PubMed Web of Science ®Google Scholar
• Garabedian MJ, Hansen WF, McCord LA, Man- Ning MA, O’Brien JM, Curry TE Jr. Up-regulation of oxytocin receptor expression at term is related to maternal body mass index. Am J Peri- Natol. 2013;30(6):491–497. doi:10.1055/s-0032-1329179
   PubMed Web of Science ®Google Scholar
• Chen W, Xue J, Peprah MK, et al. A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour. BJOG. 2016;123(3):346–354. doi:10.1111/1471-0528.13456
   PubMed Web of Science ®Google Scholar
• Yan F. Comparison of the clinical effects of dinoprost routine placement time and shortened placement time in promoting cervical maturation induced labor. J Contemp Med. 2020;26(3):554.
   Google Scholar
• Saunders SJ, Saunders R, Wong T, et al. Out-of-hospital cervical ripening with a synthetic hygroscopic cervical dilator may reduce hospital costs and cesarean sections in the United States-a cost-consequence analysis. Front Public Health. 2021;9(9):689115. doi:10.3389/fpubh.2021.689115
   PubMedGoogle Scholar
• Hayes-Larson E, Kezios KL, Mooney SJ, et al. Who is in this study, anyway? Guidelines for a useful Table 1. J Clin Epidemiol. 2019;114:125–132. doi:10.1016/j.jclinepi.2019.06.011
   PubMed Web of Science ®Google Scholar
• Rugarn O, Tipping D, Powers B, et al. Induction of labour with retrievable prostaglandin vaginal inserts: outcomes following retrieval due to an intrapartum adverse event. Int J Obstet Gynaecol. 2017;124(5):796–803. doi:10.1111/1471-0528.14147
   Web of Science ®Google Scholar
• Aghideh FK, Mullin PM, Ingles S, et al. A comparison of obstetrical outcomes with labor induction agents used at term. J Matern Fetal Neonatal Med. 2014;27(6):592–596. doi:10.3109/14767058.2013.831066
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Keeney E, Dowswell T, et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. Br Med J. 2015;2015:350.
   Google Scholar
• Zeng X, Zhang Y, Tian Q, et al. Efficiency of dinoprostone insert for cervical ripening and induction of labor in women of full-term pregnancy compared with dinoprostone gel: a meta-analysis. Drug Discoveries Ther. 2015;9(3):165–172. doi:10.5582/ddt.2015.01033
   PubMed Web of Science ®Google Scholar
• Cromi A, Ghezzi F, Uccella S, et al. A randomized trial of prein- duction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter. Am J Clin Exp Obstet Gynecol. 2012;207(2):1–7. doi:10.1016/j.ajog.2012.05.020
   Google Scholar
• Rouzi A, Alsibiani S, Mansouri N, et al. Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. Am J Clin Exp Obstet Gynecol. 2014;210(1):56.e1–56.e6. doi:10.1016/j.ajog.2013.08.033
   Google Scholar
• Levine L, Downes K, Elovitz M, et al. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstetrics Gynecol. 2016;128(6):1357–1364. doi:10.1097/AOG.0000000000001778
   PubMed Web of Science ®Google Scholar
• Baev OR, Rumyantseva VP, Tysyachnyu OV, et al. Outcomes of mifepristone usage for cervical ripening and induction of labour in full-term pregnancy. Randomized controlled trial. Eur J Obstetrics Gynecol Reprod Biol. 2017;217:144–149. doi:10.1016/j.ejogrb.2017.08.038
   PubMed Web of Science ®Google Scholar
• Baev O, Karapetian A, Babich D, et al. Comparison of outpatient with inpatient mifepristone usage for cervical ripening: a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol: X. 2023;16(18):100198. doi:10.1016/j.eurox.2023.100198
   Google Scholar
• Adelson PL, Wedlock GR, Wilkinson CS, et al. A cost analysis of inpatient compared with outpatient prostaglandin E2 cervical priming for induction of labour: results from the OPRA trial. Aust Health Rev. 2013;37(4):467–473. doi:10.1071/AH13081
   PubMed Web of Science ®Google Scholar
• Wilkinson C, Bryce R, Adelson P, et al. A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E₂ (OPRA study). BJOG. 2015;122(1):94–104. doi:10.1111/1471-0528.12846
   PubMed Web of Science ®Google Scholar